Profile data is unavailable for this security.
About the company
Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.
- Revenue in BRL (TTM)35.14bn
- Net income in BRL1.05bn
- Incorporated1935
- Employees57.71k
- LocationRaia Drogasil S/AAv. Corifeu de Azevedo Marques3.097, ButantaSAO PAULO 05.339-900BrazilBRA
- Phone+55 1 137695678
- Fax+55 1 137695687
- Websitehttps://www.rd.com.br
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sendas Distribuidora SA | 68.63bn | 698.00m | 15.48bn | 80.00k | 22.27 | 3.29 | 6.79 | 0.2255 | 0.5142 | 0.5142 | 50.63 | 3.48 | 1.70 | 8.90 | 101.37 | 857,862.50 | 1.73 | -- | 2.90 | -- | 16.31 | -- | 1.02 | -- | 0.3869 | 1.89 | 0.8427 | -- | 21.98 | -- | -41.80 | -- | -- | -- |
Grupo Mateus SA | 28.29bn | 1.22bn | 16.17bn | 29.67k | 13.23 | 1.83 | 9.17 | 0.5717 | 0.5531 | 0.5531 | 12.81 | 3.99 | 1.87 | 4.70 | 10.34 | -- | 8.17 | 9.10 | 10.76 | 11.61 | 22.00 | 22.85 | 4.37 | 4.87 | 1.22 | 7.89 | 0.3073 | -- | 22.99 | 31.22 | 16.00 | 32.54 | 49.67 | -- |
Atacadao SA | 110.42bn | -643.00m | 21.38bn | 95.67k | -- | 1.11 | 14.67 | 0.1936 | -0.3051 | -0.3051 | 52.39 | 9.15 | 1.22 | 6.28 | 21.37 | -- | -0.4794 | 2.85 | -0.9556 | 5.80 | 18.93 | 19.34 | -0.3931 | 2.11 | 0.6782 | 2.80 | 0.5343 | 46.71 | 6.77 | 15.15 | -145.72 | -- | 14.43 | -15.92 |
Raia Drogasil S/A | 35.14bn | 1.05bn | 43.45bn | 57.71k | 41.27 | 7.14 | 15.35 | 1.24 | 0.6128 | 0.6128 | 20.50 | 3.54 | 1.81 | 3.40 | 13.03 | 609,158.10 | 5.57 | 5.78 | 9.51 | 9.25 | 30.01 | 29.92 | 3.08 | 3.33 | 0.5188 | 3.19 | 0.5343 | 44.25 | 16.88 | 18.08 | 5.91 | 15.99 | 13.16 | 20.02 |
Data as of Jul 06 2024. Currency figures normalised to Raia Drogasil S/A's reporting currency: Brazilian Real BRL
Holder | Shares | % Held |
---|---|---|
Schroder Investment Management Ltd.as of 31 May 2024 | 56.41m | 3.28% |
RBC Global Asset Management (UK) Ltd.as of 31 May 2024 | 49.82m | 2.90% |
Fidelity Management & Research Co. LLCas of 31 May 2024 | 47.64m | 2.77% |
The Vanguard Group, Inc.as of 06 Jun 2024 | 44.62m | 2.60% |
BlackRock Fund Advisorsas of 06 Jun 2024 | 39.92m | 2.32% |
JPMorgan Asset Management (UK) Ltd.as of 30 Jun 2024 | 30.59m | 1.78% |
JPMorgan Investment Management, Inc.as of 06 Jun 2024 | 21.25m | 1.24% |
Sands Capital Management LLCas of 28 Jun 2024 | 17.11m | 1.00% |
APG Asset Management NVas of 31 Dec 2023 | 16.91m | 0.98% |
Wasatch Advisors LPas of 31 Mar 2024 | 16.89m | 0.98% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.